Skip to main content
Business Listing Info

ArteraAI vs AEONNN

A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.

ArteraAI compared with AEONNN
DetailArteraAI logo ArteraAIAEONNN logo AEONNN
What it doesPersonalized precision medicine powered by AI for cancer therapy Where longevity becomes intelligence
StageNot given MVP
FoundedNot given Not given
Based inUS US
Pricing modelContact for pricing Not given
PricingNot given Founding Membership: $1,200 one-time purchase for lifetime Evolution tier access. Standard Origin and Evolution memberships available with monthly or annual billing options.
Key features
  • Analyzes digital pathology with no additional tissue staining required
  • Rapid results within 1-2 days after specimen receipt
  • Validated across diverse populations including African American and non-African American men
  • FDA De Novo authorization for prostate cancer risk stratification
  • Insurance coverage for Medicare and many commercial plans
  • Provides 5 and 10-year distant metastasis risk for breast cancer
  • Identifies breast cancer patients who benefit from chemotherapy
  • Included in NCCN Clinical Practice Guidelines for Prostate Cancer
  • Pillar Matrix: organizes context across ten interconnected biological and lifestyle pillars
  • Stack Builder: personalized supplement guidance and product selection
  • Insight Protocol: explains relevance, priority and reasoning behind recommendations
  • AEONNN IQ: adaptive onboarding and profiling experience
  • Discovered Mode: inference-based approach using goals, routines and self-reported signals
  • Synched Mode: enriches foundation with wearable data, Apple Health and bloodwork
  • AEONNN Age: composite longevity score in age-like format for trajectory understanding
  • Contingency: rapid situational adaptation for travel, stress and routine disruption
  • AEONNN Shield: continuity protection layer tracking stack integrity and biological memory
What makes it different
  • No additional tissue preparation needed, uses existing H&E slides
  • Validated across multiple large randomized phase III clinical trials
  • FDA De Novo clearance as Software as a Medical Device
  • Financial assistance program to make tests affordable regardless of income
  • Treats optimization as continuous evolution rather than isolated one-time recommendations
  • Emphasizes structured longitudinal alignment across interconnected biological and lifestyle dimensions
  • Works without requiring blood tests or wearables as a prerequisite for use
  • Explains the reasoning and context behind supplement suggestions and health insights
Community votes00
DR (Domain Rating by Ahrefs)57 no change since last checkNot checked yet no change since last check
Trust Flow (Majestic)150
Citation Flow (Majestic)2716
Referring domains (Majestic)28517

4 details filled in for both companies.

More alternatives to ArteraAI More alternatives to AEONNN

Questions?